{"product_id":"proassurance-pestle-analysis","title":"ProAssurance PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Smarter Strategic Decisions with a Complete PESTEL View\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how political, economic, social, technological, legal, and environmental forces are reshaping ProAssurance’s risk profile and growth prospects—our concise PESTLE highlights key external drivers you need to know; purchase the full analysis for detailed, actionable insights and ready-to-use charts to inform investment or strategy decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Policy Shifts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe post-2024 federal and state policy landscape has increased uncertainty in reimbursement and insurance regulation, with Medicare outlays projected to rise to about $900 billion in 2025 and Medicaid enrollment variances affecting state budgets by up to 5% year-over-year. Changes to Medicare\/Medicaid funding directly affect ProAssurance clients’ revenue streams and their capacity to afford comprehensive liability coverage, raising claims exposure. Strategic monitoring of legislative priorities is essential as administrations implement or reverse initiatives through 2025, with potential premium and reserve impacts of several percentage points.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTort Reform Advocacy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePolitical stability and state legislative ideology strongly influence the durability of tort reform caps on non-economic damages; between 2018–2024, 12 states reversed or modified caps, increasing claims volatility for insurers like ProAssurance.\u003c\/p\u003e\n\u003cp\u003eSuch shifts raise loss unpredictability—ProAssurance reported a 15% increase in claim severity in affected jurisdictions in 2022–2023—threatening combined ratios and reserve adequacy.\u003c\/p\u003e\n\u003cp\u003eTo mitigate this, ProAssurance must sustain lobbying and coalition efforts; the industry spent over $120 million on state-level medical-liability advocacy from 2020–2024 to defend stable legal frameworks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eState Regulatory Oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInsurance regulation is state-driven; political appointments of insurance commissioners affect rate oversight and capital rules—in 2024, 38 states reported active rate review interventions impacting premium approvals. State-level political shifts influenced 2023–2024 product approvals and rate decisions, with some states imposing stricter capital guidance after natural disaster losses; ProAssurance’s diversified footprint across 45+ states reduces concentration risk from any single state’s regulatory tightening.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLife Sciences Incentives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment incentives and R\u0026amp;D tax credits boosted US life sciences investment to $112bn in 2024, expanding the med‑tech ecosystem and increasing demand for products‑liability coverage that ProAssurance supplies.\u003c\/p\u003e\n\u003cp\u003eFederal push for domestic manufacturing — including $52bn from CHIPS+‑adjacent programs and BIO policy initiatives — drives new specialized suppliers, raising exposure and premium opportunities for ProAssurance.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 US life‑sciences funding: $112bn\u003c\/li\u003e\n\u003cli\u003eDomestic manufacturing allocations impacting med‑tech: ~$52bn\u003c\/li\u003e\n\u003cli\u003eHigher number of specialized med‑tech firms → increased products‑liability demand\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Trade Relations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePolitical decisions on tariffs and trade agreements shape supply chains for ProAssurance's medical technology clients; U.S.-China tariffs and 2023 global trade frictions raised component costs by up to 12% for some medtech firms.\u003c\/p\u003e\n\u003cp\u003eTrade disruptions can cause shortages or cost inflation, increasing operational risk profiles and potential claims frequency for device manufacturers; just-in-time inventories magnify exposure.\u003c\/p\u003e\n\u003cp\u003eProAssurance must factor geopolitical tensions and a 2024 IMF-projected 2.8% global goods trade growth into life sciences business continuity assessments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTariff-driven cost rises: ~12% reported in medtech segments\u003c\/li\u003e\n\u003cli\u003eTrade growth (IMF 2024): 2.8% for goods\u003c\/li\u003e\n\u003cli\u003eHigher supply-chain disruption → elevated operational risk for policyholders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePolicy swings fuel reimbursement, tort risk and rising medtech costs—$900B Medicare, 15% claims\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePolitical shifts through 2024–25 raise reimbursement and tort-risk volatility—Medicare ~ $900B (2025 proj.), Medicaid state budget swings up to 5% YoY, 12 states altered tort caps 2018–24, 15% claim-severity rise in affected areas (2022–23); industry advocacy $120M (2020–24); US life‑sciences funding $112B (2024), domestic manufacturing ~$52B; medtech tariffs raised component costs ~12%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare outlays (2025)\u003c\/td\u003e\n\u003ctd\u003e$900B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid state budget variance\u003c\/td\u003e\n\u003ctd\u003e±5% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStates modifying tort caps (2018–24)\u003c\/td\u003e\n\u003ctd\u003e12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClaim severity rise (impacted areas)\u003c\/td\u003e\n\u003ctd\u003e15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLife‑sciences funding (2024)\u003c\/td\u003e\n\u003ctd\u003e$112B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDomestic manufacturing alloc.\u003c\/td\u003e\n\u003ctd\u003e$52B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedtech component cost rise\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect ProAssurance across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—backed by current data and trends to identify threats and opportunities for executives and investors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eSummarizes ProAssurance’s PESTLE insights into a single, shareable page that eases stakeholder briefings and supports quick decision-making during risk reviews and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe interest rate environment throughout 2025 remains a primary driver of ProAssurance’s investment income and profitability; the Fed funds rate at 5.25–5.50% (Jan 2025) lifted new fixed-income yields while pressuring existing holdings. ProAssurance’s ~$4.2bn fixed-income portfolio is duration-sensitive, so rising rates improved book yield but caused $120–180m of unrealized AOCI losses in 2024–2025, necessitating active duration management.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Cost Inflation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cprising medical procedure hospital and specialty treatment costs price inflation rose about in average charges per admission over from pl claim severity for proassurance forcing more frequent adjustments to loss reserves premium rates protect solvency. must deploy advanced actuarial models stress tests as cost outpaces cpi with reserve adequacy reviews tied real-world trends metrics.\u003e\n\u003c\/prising\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Market Dynamics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePersistent shortages of qualified U.S. healthcare professionals—the AAMC projects a physician shortfall of up to 37,800–124,000 by 2034—raise workloads and error risk, increasing malpractice claim frequency against ProAssurance-insured providers; Moody’s reports rising claim severity in medical malpractice lines in 2024. Concurrent wage inflation for skilled claims adjusters and underwriters (U.S. compensation up ~6–8% in 2023–24) elevates ProAssurance’s operating costs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInvestment Portfolio Performance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eInvestment returns beyond interest rates, including a 7.8% U.S. equity gain in 2024 and alternative asset returns averaging 6.2%, materially affect ProAssurance’s capital surplus and RBC ratios.\u003c\/p\u003e\n\u003cp\u003eEconomic volatility in 2025—with forecasters projecting 2.1% GDP growth and higher equity dispersion—requires disciplined asset allocation to shield the balance sheet from downturns.\u003c\/p\u003e\n\u003cp\u003eStrong investment returns act as a cushion in soft insurance pricing cycles, helping sustain underwriting capacity and competitive positioning.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 U.S. equity +7.8% \/ alternatives +6.2%\u003c\/li\u003e\n\u003cli\u003e2025 GDP forecast ~2.1% — higher market dispersion\u003c\/li\u003e\n\u003cli\u003eInvestment cushion supports RBC and underwriting flexibility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eWorkers Compensation Trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe economic health of the U.S. workforce drives ProAssurance’s workers’ comp premium volume; U.S. payrolls rose 3.8% YoY in 2025, supporting higher exposures while unemployment held near 3.7%.\u003c\/p\u003e\n\u003cp\u003eShifts toward healthcare and technical labor increase claim severity; national workplace injury rates ticked up 1.2% in 2024, influencing reserves and pricing.\u003c\/p\u003e\n\u003cp\u003eProAssurance tracks payroll, employment, and rehab costs—vocational rehab inflation ran ~4.5% in 2024—to adjust underwriting and loss forecasts.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePayroll growth +3.8% (2025) impacts premiums\u003c\/li\u003e\n\u003cli\u003eUnemployment ~3.7% (2025) alters exposure\u003c\/li\u003e\n\u003cli\u003eWorkplace injuries +1.2% (2024) raise severity\u003c\/li\u003e\n\u003cli\u003eVocational rehab inflation ~4.5% (2024) affects costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProAssurance 2024–25: Rising rates dent AOCI; equity gains bolster surplus amid higher claims\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic drivers for ProAssurance in 2024–25: higher Fed rates (5.25–5.50% Jan 2025) raised fixed-income yields but created $120–180m AOCI hits; 2024 U.S. equity +7.8% and alternatives +6.2% bolstered surplus; medical\/hospital inflation (~6.7% hospital price inflation 2023) and physician shortages (AAMC gap up to 124k by 2034) increased claim severity; 2025 GDP ~2.1% and payrolls +3.8% raised exposure.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFed funds (Jan 2025)\u003c\/td\u003e\n\u003ctd\u003e5.25–5.50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFixed-income AOCI loss\u003c\/td\u003e\n\u003ctd\u003e$120–180m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eU.S. equity 2024\u003c\/td\u003e\n\u003ctd\u003e+7.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital price inflation 2023\u003c\/td\u003e\n\u003ctd\u003e6.7%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGDP 2025 forecast\u003c\/td\u003e\n\u003ctd\u003e~2.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePayrolls YoY 2025\u003c\/td\u003e\n\u003ctd\u003e+3.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eProAssurance PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact ProAssurance PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751553282425,"sku":"proassurance-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/proassurance-pestle-analysis.png?v=1772232958","url":"https:\/\/matrixbcg.com\/products\/proassurance-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}